Reason for request

Renewal of inclusion

-


Clinical Benefit

Substantial

The Committee considers that the actual benefit of ALTIM remains substantial in rheumatological diseases :

- In intra-articular injection: inflammatory arthritis, advanced osteoarthritis.

- In periarticular injection: tendinitis, bursitis.

- In injection of soft tissue: talalgia, carpal tunnel syndrome, Dupuytren's contracture.

Unspecified

The Committee does not make any comment on the actual benefit of ALTIM in the epidural injection indication : radiculalgia, pending the re-assessment of ALTIM 3.75 mg/1.5 ml suspension for injection an d HYDROCORTANCYL 2.5 % suspension for injection in this single indication.